Yuji Yada

490 total citations
19 papers, 233 citations indexed

About

Yuji Yada is a scholar working on Psychiatry and Mental health, Pharmacology and Neurology. According to data from OpenAlex, Yuji Yada has authored 19 papers receiving a total of 233 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Psychiatry and Mental health, 4 papers in Pharmacology and 3 papers in Neurology. Recurrent topics in Yuji Yada's work include Schizophrenia research and treatment (13 papers), Bipolar Disorder and Treatment (11 papers) and Autoimmune Neurological Disorders and Treatments (3 papers). Yuji Yada is often cited by papers focused on Schizophrenia research and treatment (13 papers), Bipolar Disorder and Treatment (11 papers) and Autoimmune Neurological Disorders and Treatments (3 papers). Yuji Yada collaborates with scholars based in Japan, Malaysia and Armenia. Yuji Yada's co-authors include Manabu Takaki, Norihito Yamada, Ryuhei So, Yuko Okahisa, Shinji Sakamoto, Yoshiki Kishi, N. Hashimoto, Soshi Takao, Masafumi Kodama and Atsushi Ozawa and has published in prestigious journals such as SHILAP Revista de lepidopterología, Schizophrenia Bulletin and Psychopharmacology.

In The Last Decade

Yuji Yada

18 papers receiving 226 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuji Yada Japan 7 167 35 33 30 24 19 233
Marcos Gómez‐Revuelta Spain 11 228 1.4× 27 0.8× 33 1.0× 48 1.6× 62 2.6× 35 319
Valerie Powell Canada 10 217 1.3× 49 1.4× 18 0.5× 41 1.4× 24 1.0× 18 321
Ivo Caers Belgium 8 153 0.9× 25 0.7× 31 0.9× 40 1.3× 31 1.3× 10 327
Mirjam van Tricht Netherlands 6 132 0.8× 31 0.9× 26 0.8× 22 0.7× 31 1.3× 9 285
Justin Faden United States 10 141 0.8× 20 0.6× 28 0.8× 27 0.9× 48 2.0× 23 249
Jiahn‐Jyh Chen Taiwan 6 92 0.6× 14 0.4× 13 0.4× 13 0.4× 19 0.8× 15 152
N. Bergemann Germany 9 150 0.9× 23 0.7× 8 0.2× 44 1.5× 20 0.8× 23 329
Niko Seppälä Finland 12 251 1.5× 89 2.5× 28 0.8× 53 1.8× 29 1.2× 20 398
James E. Emanuel United States 8 177 1.1× 22 0.6× 14 0.4× 27 0.9× 25 1.0× 12 300
Adam Simmons United States 11 239 1.4× 31 0.9× 25 0.8× 93 3.1× 36 1.5× 30 353

Countries citing papers authored by Yuji Yada

Since Specialization
Citations

This map shows the geographic impact of Yuji Yada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuji Yada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuji Yada more than expected).

Fields of papers citing papers by Yuji Yada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuji Yada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuji Yada. The network helps show where Yuji Yada may publish in the future.

Co-authorship network of co-authors of Yuji Yada

This figure shows the co-authorship network connecting the top 25 collaborators of Yuji Yada. A scholar is included among the top collaborators of Yuji Yada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuji Yada. Yuji Yada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Kikuchi, Yuki, Yuji Otsuka, Fumiaki Ito, et al.. (2024). Relationship Between Clozapine-Induced Inflammation and Eosinophilia: A Retrospective Cohort Study. Schizophrenia Bulletin. 52(1). 2 indexed citations
2.
Kikuchi, Yuki, Hiroshi Komatsu, Yuji Otsuka, et al.. (2024). Effect of concomitant use of valproic acid during clozapine initiation on clozapine-induced inflammation among Japanese patients with schizophrenia. Psychiatry Research. 334. 115810–115810. 6 indexed citations
3.
4.
Kikuchi, Yuki, Yuji Yada, Yuji Otsuka, et al.. (2023). Slower clozapine titration is associated with delayed onset of clozapine-induced fever among Japanese patients with schizophrenia. SHILAP Revista de lepidopterología. 9(1). 82–82. 7 indexed citations
5.
So, Ryuhei, Yuji Yada, Masafumi Kodama, et al.. (2023). Effect of smoking habits and concomitant valproic acid use on relapse in patients with treatment‐resistant schizophrenia receiving clozapine: A 1‐year retrospective cohort study. Acta Psychiatrica Scandinavica. 148(5). 437–446. 3 indexed citations
6.
Yada, Yuji, Shinji Sakamoto, Yuko Okahisa, et al.. (2022). The validity of atypical psychosis diagnostic criteria to detect anti-NMDA receptor encephalitis with psychiatric symptoms. Schizophrenia Research. 248. 292–299. 7 indexed citations
7.
Matsuo, Kazuhiro, K. Moriyama, Tatsuro Yamamoto, et al.. (2021). Risk factors for clozapine-induced central nervous system abnormalities in Japanese patients with treatment-resistant schizophrenia. Asian Journal of Psychiatry. 60. 102652–102652. 5 indexed citations
8.
9.
Sakamoto, Shinji, Yuko Okahisa, Yuji Yada, et al.. (2020). Mechanisms Underlying the Comorbidity of Schizophrenia and Type 2 Diabetes Mellitus. The International Journal of Neuropsychopharmacology. 24(5). 367–382. 49 indexed citations
10.
Yada, Yuji, Shinji Sakamoto, Atsushi Ozawa, et al.. (2020). The relationship between plasma clozapine concentration and clinical outcome: a cross‐sectional study. Acta Psychiatrica Scandinavica. 143(3). 227–237. 32 indexed citations
11.
Takaki, Manabu, Shinji Sakamoto, Takashi Shibata, et al.. (2019). Anti-NMDA-receptor antibody in initial diagnosis of mood disorder. European Neuropsychopharmacology. 29(9). 1041–1050. 9 indexed citations
12.
Mitsui, Satoshi, Shinji Sakamoto, Yuji Yada, et al.. (2019). Switching strategies for antipsychotic monotherapy in schizophrenia: a multi-center cohort study of aripiprazole. Psychopharmacology. 237(1). 167–175. 6 indexed citations
13.
Higuchi, Yuji, Masaki Fujiwara, Naoki Nakaya, et al.. (2019). Change in smoking cessation stage over 1 year in patients with schizophrenia: a follow up study in Japan. BMC Psychiatry. 19(1). 367–367. 5 indexed citations
14.
Kishi, Yoshiki, et al.. (2018). Two-year effectiveness of risperidone and aripiprazole in the maintenance treatment of patients with recent-onset or chronic schizophrenia and related psychotic disorders. International Clinical Psychopharmacology. 33(3). 147–154. 1 indexed citations
15.
Takaki, Manabu, et al.. (2018). Case Report: Augmentation with Blonanserin for a Schizophrenia Patient with Insufficient Response to Clozapine. Open Journal of Psychiatry. 8(2). 131–136. 1 indexed citations
16.
Yada, Yuji, et al.. (2017). The critical treatment window of clozapine in treatment-resistant schizophrenia: Secondary analysis of an observational study. Psychiatry Research. 250. 65–70. 81 indexed citations
17.
Kishi, Yoshiki, et al.. (2017). Optimal Dosing of Risperidone and Olanzapine in the Maintenance Treatment for Patients With Schizophrenia and Related Psychotic Disorders. Journal of Clinical Psychopharmacology. 37(3). 296–301. 4 indexed citations
18.
Takehisa, Yasushi, Yuji Yada, Yoshiki Kishi, et al.. (2016). Encephalitis With Antibodies to GluN2B During Administration of Clozapine. Clinical Neuropharmacology. 39(6). 320–321. 2 indexed citations
19.
Tanaka, Fujio, K. Morimoto, Hiroshi Kubo, et al.. (1997). Comparative study on the photodynamics of chloromethylanthracenes in a supersonic free jet and solution. Journal of the Chemical Society Faraday Transactions. 93(17). 3013–3019. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marcos Gómez‐Revuelta Breakdown of academic impact, for papers by Valerie Powell Breakdown of academic impact, for papers by Ivo Caers Breakdown of academic impact, for papers by Mirjam van Tricht Breakdown of academic impact, for papers by Justin Faden Breakdown of academic impact, for papers by Jiahn‐Jyh Chen Breakdown of academic impact, for papers by N. Bergemann Breakdown of academic impact, for papers by Niko Seppälä Breakdown of academic impact, for papers by James E. Emanuel Breakdown of academic impact, for papers by Adam Simmons
Rankless by CCL
2026